Navigation Links
22 of America's Most Promising Scientists Selected as 2011 Pew Scholars in the Biomedical Sciences
Date:6/13/2011

e program. "From my own experience as a Pew Scholar and member of the advisory board, this program gives young scientists the confidence to pursue risky projects, and to push the boundaries of their fields, planting the seeds for major scientific advancements.  I welcome these promising scientists into the Pew Biomedical Scholars family and look forward to watching as their research unfolds in the years ahead."

The new 2011 Pew Scholars are:


  • Christine M. Dunham, Ph.D.

  • Emory University School of Medicine Structural Biology and Pathogenesis


  • Thomas G. Fazzio, Ph.D.

  • University of Massachusetts Medical SchoolStem Cell Biology


  • Max L. Fletcher, Ph.D.

  • University of Tennessee Health Science CenterNeuroscience


  • Hunter B. Fraser, Ph.D.

  • Stanford UniversityGene Regulation


  • Melissa K. Gardner, Ph.D.

  • University of MinnesotaCell Biology and Biophysics


  • Mary Gehring, Ph.D.

  • Whitehead Institute for Biomedical ResearchGene Regulation and Epigenetics


  • Jeff Gore, Ph.D.

  • Massachusetts Institute of TechnologyBiophysics and Systems Biology


  • Takaki Komiyama, Ph.D.

  • University of California, San DiegoNeuroscience


  • Mei Kong, Ph.D.

  • Beckman Institute, City of Hope Cancer Cell Biology


  • Michael S. Kuhns, Ph.D.

  • University of ArizonaImmunology


  • Erica Larschan, Ph.D.

  • Brown UniversityEpigenetics


  • Eros Lazzerini Denchi, Ph.D.

  • Scripps Research
    '/>"/>

    SOURCE The Pew Charitable Trusts
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4

    Related biology technology :

    1. Terumo Americas Holding, Inc., Agrees to Acquire Harvest Technologies Corporation, a Leader in the Development of Point-of-Care Cellular Therapy
    2. iLife Americas, LLC Enters U.S. Wellness and Therapeutic Markets
    3. Americas on the Waterway Supports US Oncology Foundation
    4. Cochlear Americas Provides Support for Cochlear Implant Recipients to Pursue Higher Education
    5. Abbott to Present at UBS Best of Americas Investment Conference
    6. Jennerex and Partners Present Positive JX-594 Randomized Phase 2 Clinical Data Showing Promising Survival Benefit in Patients with Advanced Liver Cancer
    7. Ontario Institute for Cancer Research Announces Spin Off Companies Developing Promising Anticancer Technologies
    8. Reportlinker Adds Pipeline Insight: Cancer Overview- Breast and Gynecological Cancers - Promising agents emerge for BRCA positive patients
    9. Early Safety Results Promising for Phase I/II Trial of Gene Therapy Treatment of Hemophilia B
    10. New findings promising for transformation optics, cloaking
    11. New hydrolysis model promising tool in cellulosic biofuel studies
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:11/26/2014)... Bio-Techne Corporation (NASDAQ: TECH ) announced today ... serve in a newly created position of Senior Vice ... be responsible for managing the operations of Bio-Techne,s Protein ... in July 2014 and the recently acquired CyVek business. ... ProteinSimple develops and commercializes proprietary systems and consumables that ...
    (Date:11/24/2014)... WASHINGTON , Nov. 24, 2014  Last ... G.K. Butterfield (D-NC) took a bold ... diseases by introducing the OPEN Act. Original co-sponsors ... Hastings (D-FL). The Act will incentivize drug makers ... life-threatening rare diseases and pediatric cancers, which opens ...
    (Date:11/24/2014)... 2014 Continental Clinical Solutions, LLC ... clinical trials at its mid-Atlantic late-phase research facility, ... created with the idea of closing patient disparities ... in medical advances," said Continental's CEO, Saleh ... the immortal cell line of Henrietta Lacks, dubious ...
    (Date:11/23/2014)... St. Francis, WI (PRWEB) November 23, 2014 ... based manufacturer and supplier of fine chemical ingredients ... industries announced the launch of its new website, ... a description of Apiscent Labs, clean design, easy ... qualities that make Apiscent Labs stand out. ...
    Breaking Biology Technology:Bio?Techne Announces Appointment Of Robert Gavin As Leader Of New Protein Platforms Division 2Bio?Techne Announces Appointment Of Robert Gavin As Leader Of New Protein Platforms Division 3OPEN Act Introduced to Repurpose Drugs for Rare Diseases 2At Continental Clinical Solutions, CEO Saleh Stevens Focuses on Diversity in Clinical Trial Recruitment at Maryland Site 2At Continental Clinical Solutions, CEO Saleh Stevens Focuses on Diversity in Clinical Trial Recruitment at Maryland Site 3
    ... July 1 Galaxy Nutritional,Foods, Inc. (OTC Bulletin Board: ... dairy and other organic and natural food,products, today reported ... March 31, 2008. The Company will host an investor,conference ... Time (EDT),today, July 1, 2008 (see details below)., ...
    ... Agency Contract Will Support Development of Bavituximab and ... ... July 1 Peregrine,Pharmaceuticals, Inc. (Nasdaq: PPHM ), a ... cancer and,hepatitis C virus (HCV) infection, today announced it has ...
    ... (Nasdaq: ISIS ) announces the following webcast:, What: ... update, When: ... PT Via internet: Simply log onto our web site http://www.isispharm.com ... telephone: In the United States, call 1-877-548-7901 five to ten,minutes prior to ...
    Cached Biology Technology:Galaxy Nutritional Foods Reports FY2008 Results 2Galaxy Nutritional Foods Reports FY2008 Results 3Galaxy Nutritional Foods Reports FY2008 Results 4Galaxy Nutritional Foods Reports FY2008 Results 5Galaxy Nutritional Foods Reports FY2008 Results 6Galaxy Nutritional Foods Reports FY2008 Results 7Galaxy Nutritional Foods Reports FY2008 Results 8Galaxy Nutritional Foods Reports FY2008 Results 9Peregrine Pharmaceuticals Awarded DTRA Contract Worth up to $44.4 Million to Develop Bavituximab for Viral Hemorrhagic Fevers 2Peregrine Pharmaceuticals Awarded DTRA Contract Worth up to $44.4 Million to Develop Bavituximab for Viral Hemorrhagic Fevers 3Peregrine Pharmaceuticals Awarded DTRA Contract Worth up to $44.4 Million to Develop Bavituximab for Viral Hemorrhagic Fevers 4Peregrine Pharmaceuticals Awarded DTRA Contract Worth up to $44.4 Million to Develop Bavituximab for Viral Hemorrhagic Fevers 5Webcast Alert: Isis Pharmaceuticals Announces a Business Update Conference Call 2
    (Date:11/6/2014)... team of Florida State University biologists could lead to ... and survive environmental swings such as droughts or floods. ... the journal The Plant Cell , sheds light ... is organized in a cell and how plants regulate ... and others are turned off. , "If you understand ...
    (Date:11/5/2014)... Fidel Santamaria, associate professor of biology in the ... researchers in the nation selected to receive a ... Grant for Exploratory Research (EAGER). The funding supports ... support researchers to create new technology that will ... Santamaria, complex behaviors in neuroscience are broken into ...
    (Date:11/4/2014)... the right time might actually help boost a species, ... in understanding animal populations, pest control and managing fish ... journal Trends in Ecology and Evolution , a ... kind of positive population effect an overall species experiences ... the size and developmental stage of the creatures that ...
    Breaking Biology News(10 mins):Maize analysis yields whole new world of genetic science 2UTSA biology professor awarded $300,000 NSF grant for brain research 2UTSA biology professor awarded $300,000 NSF grant for brain research 3When less is more: Death in moderation boosts population density in nature 2
    ... the winners of its student travel award to attend ... Convention Center in San Francisco, California, February 20-24, 2010. ... on scientific merit, with priority given to those who ... awardee receives a travel grant and will be recognized ...
    ... World Bank is a vital source of financial and ... first glance, this may not appear to be connected ... state of Earth,s environment are intrinsically linked. Global ... overcoming poverty and advancing development in the poorest countries ...
    ... that short-term, seasonal exposure to pesticides in rivers and ... salmon populations. In addition to the widespread deterioration of ... used pesticides may further inhibit the recovery of threatened ... underway to restore Pacific salmon habitats in an effort ...
    Cached Biology News:Biophysical Society announces winners of 2010 Student Travel Awards 2Biophysical Society announces winners of 2010 Student Travel Awards 3Biophysical Society announces winners of 2010 Student Travel Awards 4ESA and World Bank move toward closer collaboration 2ESA and World Bank move toward closer collaboration 3ESA and World Bank move toward closer collaboration 4Even at sublethal levels, pesticides may slow the recovery of wild salmon populations 2
    Size & Applications: 20 ml Storage Temp.: -20C Shelf Life: 12 months ...
    ... Clone/PAD: ZMD.368. Immunogen: Synthetic ... of the human WNT2B/WNT13 protein. ... human mouse and rat WNT2B/WNT13 proteins. ... isoforms. Reactivity: Mouse Human Rat ...
    Request Info...
    ... Peptide sequences: Two separate ... corresponding to the same sequence used ... antiserum (Catalog No. 160890) ... with Cayman's guanylate cyclase polyclonal antiserum ...
    Biology Products: